Skip to Content
Merck
CN
  • A comparison of the in vitro biotransformation of (-)-epicatechin and procyanidin B2 by human faecal microbiota.

A comparison of the in vitro biotransformation of (-)-epicatechin and procyanidin B2 by human faecal microbiota.

Molecular nutrition & food research (2009-11-28)
Stavroula Stoupi, Gary Williamson, J Warren Drynan, Denis Barron, Michael N Clifford
ABSTRACT

The catabolism by human faecal microbiota of (-)-epicatechin (1) (2, 3-cis stereochemistry) and its dimer pure procyanidin B2 (2), has been compared using a static in vitro culture model. The catabolites were characterised by LC-MS(n), UV absorption and relative retention time, and quantified relative to standards. No more than approximately 10% of procyanidin B2 (2) was converted to epicatechin (1) by scission of the interflavan bond. Five phenolic acid catabolites (M(r)<290) were unique to 2, and ten phenolic acid catabolites (M(r)<290) were common to both substrates. The dominant catabolites (> or =24 h incubation) were 5-(3'-hydroxy phenyl) valeric acid (9), 3-(3'-hydroxyphenyl) propionic acid (10) and phenyl acetic acid (12) (maximum yields 27.4+/-4.2, 38.2+/-4.2, 22.7+/-2.9%, respectively, from 1 and 9.4+/-1.2, 52.8+/-2.1, 28.8+/-1.6%, respectively, from 2). Substrate 2 was degraded twice as rapidly as 1. Evidence is presented for the production of previously unreported catabolites of 2 that retain the flavanol A-ring and the C4-->C8 interflavan bond. It was confirmed that catabolism favoured removal of the 4'-hydroxyl rather than the 3'-hydroxyl group and that both beta-oxidation and alpha-oxidation occurred.

MATERIALS
Product Number
Brand
Product Description

Supelco
Procyanidin B2, analytical standard